A key question in the field of neurological diseases is that of how specific mutations support normal development of the nervous system but then cause subsequent dysfunction? For some genetic diseases this is due to accumulation of toxic products as in enzyme deficiencies. However, in many other instances the molecular mechanism is not clear. Ataxia Telangiectasia (A-T) is one such disease. A-T's hallmark is progressive global neuronal degeneration beginning in childhood. However, there are other phenotypes associated with the disease. These include immunodeficiency, hematolymphopoietic malignancies, growth retardation, incomplete sexual maturation, oculocutaneous telangiectasias, sensitivity to ionizing radiation and premature aging. We generated mice deficient in ATM (Atm-deficient mice) that recapitulate most aspects of the human disease showing neurological dysfunction, immunologic abnormalities, growth retardation, infertility due to gamete degeneration, sensitivity to ionizing radiation, lymphoreticular malignancies, and chromosomal instability (Barlow et al., 1996). We analyzed many of the pleiotropic phenotypes found in the Atm-deficient mice. We identified defects in molecular pathways which led observed pathologies and defined a role for ATM during the cell cycle response to DNA damage caused by ionizing radiation (IR), meiosis and T-cell development (Barlow et al., 1997; Barlow et al., 1996; Barlow et al., 1997; Barlow et al., 1998. However, the function of ATM in postmitotic cells is unclear. This is particularly important in that neurodegeneration is the hallmark manifestation of A-T and most neurons are post-mitotic. This proposal seeks to build on our previous studies of ATM to begin to define its function in the brain. We plan to use our Atm-deficient to identify important physiological defects of the nervous system. A major goal is to define the role of ATM in managing oxidative stress. In addition, we plan to define the localization of the protein in the nervous system to assess if subcellular localization differs depending on cell cycle status. Finally, we plan to define strategies to follow neuronal dysfunction over time in the living animal. We hope these experiments will help define the role of ATM in the brain and also allow us to correlate anatomical, molecular and physiological abnormalities in brain function. These are critical steps for defining and initiating studies of potential therapeutic strategies.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS039601-04
Application #
6729840
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (01))
Program Officer
Horsford, Jonathan
Project Start
2001-04-20
Project End
2005-09-30
Budget Start
2004-04-01
Budget End
2005-09-30
Support Year
4
Fiscal Year
2004
Total Cost
$418,050
Indirect Cost
Name
Salk Institute for Biological Studies
Department
Type
DUNS #
078731668
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Hovatta, Iiris; Zapala, Matthew A; Broide, Ron S et al. (2007) DNA variation and brain region-specific expression profiles exhibit different relationships between inbred mouse strains: implications for eQTL mapping studies. Genome Biol 8:R25
Miles, Philip D; Treuner, Kai; Latronica, Marc et al. (2007) Impaired insulin secretion in a mouse model of ataxia telangiectasia. Am J Physiol Endocrinol Metab 293:E70-4
Carter, Todd A; Greenhall, Jennifer A; Yoshida, Shigeo et al. (2005) Mechanisms of aging in senescence-accelerated mice. Genome Biol 6:R48
Scheel, John R; Ray, Jasodhara; Gage, Fred H et al. (2005) Quantitative analysis of gene expression in living adult neural stem cells by gene trapping. Nat Methods 2:363-70
Zapala, Matthew A; Hovatta, Iiris; Ellison, Julie A et al. (2005) Adult mouse brain gene expression patterns bear an embryologic imprint. Proc Natl Acad Sci U S A 102:10357-62
Helton, Rob; Cui, Jiankun; Scheel, John R et al. (2005) Brain-specific knock-out of hypoxia-inducible factor-1alpha reduces rather than increases hypoxic-ischemic damage. J Neurosci 25:4099-107
Winrow, Christopher J; Pankratz, Daniel G; Vibat, Cecile Rose T et al. (2005) Aberrant recombination involving the granzyme locus occurs in Atm-/- T-cell lymphomas. Hum Mol Genet 14:2671-84
Treuner, Kai; Helton, Rob; Barlow, Carrolee (2004) Loss of Rad52 partially rescues tumorigenesis and T-cell maturation in Atm-deficient mice. Oncogene 23:4655-61